2019 International Congress Archives - Page 66 of 217

1:15pm-2:45pm: Virtual Reality EEG guided motor neurofeedback training has mid-term effects in Parkinson’s Disease Patients limits of stability

JP. Romero, A. Arroyo, J. Andreo, M. Del Castillo, J. Serrano, E. Rocon, N. Malpica, E. Melero, M. Gil, E. Sanz, P. Serrano, E. Rodriguez (Madrid, Spain)

Non-Pharmacological Interventions · Les Muses Terrace, Level 3

1:15pm-2:45pm: Visual assessment of dopamine transporter imaging in normal pressure hydrocephalus

KY. Kwon, H. Ju, K. Im, JY. Lee, MY. Ahn (Seoul, Republic of Korea)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Visual dysfunction and retinal thinning predict dementia risk in Parkinson’s disease

L-A. Leyland, F. Bremner, R. Mahmood, S. Hewitt, M. Durteste, M. Cartlidge, M. Lai, L. Miller, A. Saygin, P. Keane, A. Schrag, R. Weil (London, United Kingdom)

Cognition and Cognitive Disorders · Agora 3 East, Level 3

1:15pm-2:45pm: Visual hallucinations in Lewy Body Disease are characterised by impaired sensory integration

A. Zarkali, R. Adams, L. Leyland, G. Rees, R. Weil (London, United Kingdom)

Cognition and Cognitive Disorders · Agora 3 East, Level 3

1:15pm-2:45pm: Visual hallucinations in Parkinson´s disease and amyloid burden: 18F-Flutemetamol PET-MRI study

B. Fernández-Rodríguez, C. Gasca-Salas, R. Rodríguez-Rojas, P. Guida, D. Mata-Marín, I. Obeso-Martín, L. Vela, M. Garcerant-Tafur, L. García-Cañamaque, JA. Obeso (Móstoles, Spain)

Cognition and Cognitive Disorders · Agora 3 East, Level 3

1:15pm-2:45pm: Visual subnetwork dysfunction in Parkinson’s patients with primary visual hallucinations

S. Rane, A. Lenka, S. Prasad, J. Saini, M. Ingalhalikar, P. Pal (Seatle, WA, USA)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Visuoperceptual impairment: a key feature in the diagnosis of corticobasal degeneration

R. Bruffaerts, K. van Bouwel, PH. van Damme, K. Claeys, K. van Laere (Leuven, Belgium)

Cognition and Cognitive Disorders · Agora 3 East, Level 3

1:15pm-2:45pm: Visuospatial dysfunction correlates with severity of postural instability/gait disturbance symptoms in parkinson’s disease

H. Jeong, H. Kang (Changwon, Republic of Korea)

Cognition and Cognitive Disorders · Agora 3 East, Level 3

1:15pm-2:45pm: Weighting fibroblasts for future diagnostic prospect

G. Prevot, E. Bezard, L. Cognet, B. Dehay, P. Bon (Bordeaux, France)

Physiology and Pathophysiology · Les Muses, Level 3

1:15pm-2:45pm: What can predict short and long-term outcome of bilateral Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s disease?

F. Cavallieri, V. Fraix, D. Mulas, F. Bove, M. Tondelli, P. Pélissier, A. Castrioto, S. Meoni, E. Schmitt, E. Chevrier, E. Lhommée, A. Bichon, A. Kistner, C. Ardouin, P. Limousin, S. Chabardès, AL. Benabid, E. Seigneuret, P. Krack, P. Pollak, E. Moro (Grenoble, France)

Surgical Therapy · Les Muses Terrace, Level 3